Skip to main content
. Author manuscript; available in PMC: 2023 Feb 22.
Published in final edited form as: Mol Pharm. 2020 Dec 10;18(1):228–235. doi: 10.1021/acs.molpharmaceut.0c00837

Figure 1.

Figure 1.

Comparison of Advax against alum + CpG adjuvant formulations in reducing antinociception through tail flick (A, C) and hot plate (B, D) experiments. (E) Antihapten midpoint titers in sera obtained by ELISA with anti-6AM competitive IC50 values (nM) shown above each bar.